HI
SGMO

HBK Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HBK Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-26,800
Closed -$289K – 1114
2014
Q3 		$289K Buy
+26,800
New +$350K ﹤0.01% 850
2014
Q2 		– Sell
-31,900
Closed -$577K – 1023
2014
Q1 		$577K Buy
+31,900
New +$615K 0.01% 624

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HBK Investments's SGMO Position: Q4 2014 in Review

HBK Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2014, closing a stake of 26,800 shares — an estimated $289K sold.

HBK Investments first reported a position in SGMO in Q1 2014 and held it in 2 quarters. The position peaked at $577K in Q1 2014. 158 funds tracked by Wall St. Rank hold SGMO as of Q4 2014.

  • HBK Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • HBK Investments sold 26,800 SANGAMO THERAPEUTICS INC shares in Q4 2014, an estimated $289K.
  • HBK Investments first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 2 quarters.
  • HBK Investments's SANGAMO THERAPEUTICS INC position peaked at $577K in Q1 2014.
  • 158 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2014.

Based on HBK Investments's 13F filing for Q4 2014, filed 13 Feb 2015.